Brief: Priveterra Acquisition Corp. Announces Intention To Transfer To NYSE Upon Completion Of Business Combination With Aeon Biopharma, Inc.
11/07/2023 23:41
July 11 (Reuters) - Priveterra Acquisition Corp
PMGM.O :
* PRIVETERRA ACQUISITION CORP. ANNOUNCES INTENTION TO
TRANSFER TO
NYSE UPON COMPLETION OF BUSINESS COMBINATION WITH AEON
BIOPHARMA, INC.
* PRIVETERRA ACQUISITION CORP - LAST DAY OF TRADING ON
NASDAQ IS
EXPECTED TO BE ON OR ABOUT JULY 21, 2023
Source text for Eikon: ID:nBw4Q8YW8a
Further company coverage: PMGM.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aeon Biopharma
See all newsBrief: Aeon Biopharma Reports bpd Type 2A Meeting With FDA And Shareholder Approval Of The November Transactions
Brief: Aeon Biopharma Announces Execution Of Exchange Agreement With Daewoong
Brief: Aeon Biopharma Announces First Closing Of Pipe Investment And Provides Update On FDA Type 2A Meeting Scheduling
Brief: Aeon Biopharma Announces FDA bpd Type 2A Meeting For Abp-450 On November 19
Brief: Aeon Biopharma Announces CEO Transition